Lista de obras - Russell E Ware - Dominio Público Uruguay

A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy.

artículo científico publicado en 2017

A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.

artículo científico publicado en 2015

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

scientific article published on 14 June 2019

A novel G6PD mutation leading to chronic hemolytic anemia

artículo científico publicado en 2008

A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression ⬇️

artículo científico publicado el 25 de noviembre de 2011

A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia.

artículo científico publicado en 2009

A pilot study of subcutaneous decitabine in β-thalassemia intermedia ⬇️

artículo científico publicado el 23 de junio de 2011

A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola ⬇️

artículo científico publicado el 15 de octubre de 2013

Acute parvovirus B19 infection mimicking congenital dyserythropoietic anemia

artículo científico publicado en 2004

An accurate and inexpensive color-based assay for detecting severe anemia in a limited-resource setting

artículo científico publicado en 2015

AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settings

artículo científico publicado en 2020

Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia

artículo científico publicado en 2009

Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions ⬇️

artículo científico publicado el 1 de abril de 2012

Brown recluse spider (Loxosceles reclusa) envenomation leading to acute hemolytic anemia in six adolescents

artículo científico publicado en 2010

Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial

artículo científico publicado en 2018

Case Report: β-thalassemia major on the East African coast

artículo científico publicado en 2022

Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease

artículo científico publicado en 2015

Chemical and functional analysis of generic hydroxyurea formulations

artículo científico publicado en 2008

Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease

scientific article published on January 2003

Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure

artículo científico publicado en 2011

Chronic transfusion practice for children with sickle cell anaemia and stroke

artículo científico publicado en 2008

Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities ⬇️

artículo científico publicado el 9 de enero de 2012

Clinical Features of β-Thalassemia and Sickle Cell Disease

artículo científico publicado en 2017

Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children

artículo científico publicado en 2003

Current Management of Sickle Cell Anemia ⬇️

artículo científico publicado el 1 de agosto de 2013

Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia

artículo científico publicado en 2015

Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults

artículo científico publicado en 2018

EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.

artículo científico publicado en 2016

Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study

artículo científico publicado en 2002

Effect of hydroxyurea treatment on renal function parameters: Results from the multi‐center placebo‐controlled BABY HUG clinical trial for infants with sickle cell anemia ⬇️

artículo científico publicado el 31 de enero de 2012

Effective screening leads to better outcomes in sickle cell disease

artículo científico publicado en 2018

Effects of hydroxyurea treatment for patients with hemoglobin SC disease

artículo científico publicado en 2015

Electrochemical Determination of Hydroxyurea in a Complex Biological Matrix Using MoS<sub>2</sub>-Modified Electrodes and Chemometrics

artículo científico publicado en 2020

Empowering newborn screening programs in African countries through establishment of an international collaborative effort

artículo científico publicado en 2020

Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia

artículo científico publicado en 2011

Evidence gaps in the management of sickle cell disease: A summary of needed research

artículo científico publicado en 2015

From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia

artículo científico publicado en 2014

Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia

artículo científico publicado en 2016

Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia ⬇️

artículo científico publicado el 19 de febrero de 2013

Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes ⬇️

artículo científico publicado el 30 de mayo de 2013

Genetic predictors for stroke in children with sickle cell anemia ⬇️

artículo científico publicado el 22 de abril de 2011

Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY‐HUG phase III clinical trial ⬇️

artículo científico publicado el 19 de octubre de 2011

Glomerular hyperfiltration and albuminuria in children with sickle cell anemia ⬇️

artículo científico publicado el 11 de mayo de 2011

Hemodynamic responses to visual stimulation in children with sickle cell anemia

artículo científico publicado en 2011

Hemoglobin variants identified in the Uganda Sickle Surveillance Study

artículo científico publicado en 2016

Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia

artículo científico publicado en 2012

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

artículo científico publicado en 2011

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority tria

artículo científico publicado en 2015

Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa

artículo científico publicado en 2020

Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS)

artículo científico publicado en 2020

Hydroxyurea Pharmacokinetics in Pediatric Patients After Total Pancreatectomy With Islet Autotransplantation

artículo científico publicado en 2020

Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.

artículo científico publicado en 2015

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

artículo científico publicado en 2019

Hydroxyurea for children with sickle cell anemia: Prescribe it early and often

scientific article published on 30 April 2019

Hydroxyurea for children with sickle cell disease

artículo científico publicado en 2008

Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? ⬇️

artículo científico publicado el 1 de mayo de 2011

Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease

artículo científico publicado en 2007

Hydroxyurea therapy for sickle cell anemia

artículo científico

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia

artículo científico publicado en 2007

Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin

artículo científico publicado en 2011

Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model

artículo científico publicado en 2010

Hydroxyurea to lower TCD velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort

scientific article published on 24 October 2019

Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia ⬇️

artículo científico publicado el 17 de diciembre de 2012

Hydroxyurea: Analytical techniques and quantitative analysis

artículo científico publicado en 2017

Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease.

artículo científico publicado en 2003

IgA‐mediated autoimmune hemolytic anemia in an infant ⬇️

artículo científico publicado el 22 de diciembre de 2010

Immunologic effects of hydroxyurea in sickle cell anemia

artículo científico publicado en 2014

Impact of hydroxyurea on clinical events in the BABY HUG trial

artículo científico publicado en 2012

Interpretation of fetal hemoglobin only on newborn screening for hemoglobinopathy

artículo científico publicado en 2002

Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohorts.

artículo científico publicado en 2017

Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease

artículo científico publicado en 2021

Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial

artículo científico publicado en 2015

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study

artículo científico publicado en 2005

Long‐term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload ⬇️

artículo científico publicado el 1 de abril de 2011

Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial

artículo científico publicado en 2014

Malignancy in patients with sickle cell disease

artículo científico publicado en 2003

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members

artículo científico publicado en 2014

Massive accidental overdose of hydroxyurea in a young child with sickle cell anemia ⬇️

artículo científico publicado el 8 de julio de 2011

Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia

artículo científico publicado en 2009

Model-based dosing with concentration feedback as an integral part of personalized hydroxycarbamide management

artículo científico publicado en 2018

Neurocognitive development of young children with sickle cell disease through three years of age.

artículo científico publicado en 2002

Newborn Screening With Sickle Cell Point of Care: A Valuable Resource in Low-Income Settings

scientific article published on 17 September 2019

Novel Dose Escalation to Predict Treatment with Hydroxyurea (NDEPTH): A Randomized Controlled Trial of a Dose-Prediction Equation to Determine Maximum Tolerated Dose of Hydroxyurea in Pediatric Sickle Cell Disease

artículo científico publicado en 2020

Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial

artículo científico publicado en 2016

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia

artículo científico publicado en 2017

Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial

artículo científico publicado en 2015

Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics ⬇️

artículo científico publicado el 28 de agosto de 2013

Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial

artículo científico publicado en 2013

Partial splenectomy for children with congenital hemolytic anemia and massive splenomegaly

artículo científico publicado en 2008

Pelger-Huët anomaly in a child with 1q42.3-44 deletion

artículo científico publicado en 2006

Perceived benefits and risks of participation in a clinical trial for Ugandan children with sickle cell anemia

artículo científico publicado en 2019

Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia ⬇️

artículo científico publicado el 29 de agosto de 2011

Pilot of the Chronic Disease Self-Management Program for Adolescents and Young Adults With Sickle Cell Disease

artículo científico publicado en 2016

Practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoption

Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy ⬇️

artículo científico publicado el 1 de enero de 2002

Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea

artículo científico publicado en 2008

Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children

artículo científico publicado en 2018

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy

artículo científico publicado en 2004

R2* magnetic resonance imaging of the liver in patients with iron overload

scientific article published on 04 March 2009

RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia ⬇️

artículo científico publicado el 27 de mayo de 2013

Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa

artículo científico publicado en 2018

Reply to iManage: A novel self-management app for sickle cell disease

artículo científico publicado en 2016

Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia

artículo científico publicado en 2019

Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research.

artículo científico publicado en 2016

Sickle cell disease

artículo científico publicado en 2017

Sickle cell screening in Europe: the time has come

scientific article published on 14 November 2018

Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers

scientific article published on 16 May 2019

Sickle-cell disease: an ounce of prevention, a pound of cure

artículo científico publicado en 2009

Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell disease

artículo científico publicado en 2009

Stable-Isotope Dilution HPLC-Electrospray Ionization Tandem Mass Spectrometry Method for Quantifying Hydroxyurea in Dried Blood Samples

artículo científico publicado en 2016

Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia

artículo científico publicado en 2017

Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) ⬇️

artículo científico publicado el 7 de febrero de 2012

Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload ⬇️

artículo científico publicado el 8 de agosto de 2011

Subclinical parvovirus B19 infection in children with sickle cell anemia

artículo científico publicado en 2003

Surveillance for sickle cell disease, United Republic of Tanzania

scientific article published on 28 September 2020

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

artículo científico publicado en 2003

The Clinical and Laboratory Spectrum of Hb C [β6(A3)Glu→Lys,GAG>AAG] Disease ⬇️

artículo científico publicado el 1 de enero de 2013

The diagnostic dilemma of congenital unstable hemoglobinopathies ⬇️

artículo científico publicado el 15 de diciembre de 2010

The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia

artículo científico publicado en 2008

The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design

artículo científico publicado en 2010

The second century of sickle cell disease ⬇️

artículo científico publicado el 4 de mayo de 2012

Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload

artículo científico publicado en 2015

Thrombopoiesis: new ITP paradigm? ⬇️

artículo científico publicado el 7 de julio de 2011

Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters ⬇️

artículo científico publicado el 21 de enero de 2011

Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention ⬇️

artículo científico publicado el 25 de noviembre de 2011

Translating sickle cell guidelines into practice for primary care providers with Project ECHO.

artículo científico publicado en 2016

UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia

artículo científico publicado en 2003

UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia

artículo científico publicado en 2008

Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG).

artículo científico publicado en 2010

Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia

artículo científico publicado en 2014

Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia

scientific article published on 03 August 2017

Your tired, your poor, your huddled masses

scientific article published on 01 May 2019

β-Thalassemia pathogenic variants in a cohort of children from the East African coast

scientific article published on 11 May 2020

Lista de obras de Russell E Ware

A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy.

A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

A novel G6PD mutation leading to chronic hemolytic anemia

A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression ⬇️

A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia.

A pilot study of subcutaneous decitabine in β-thalassemia intermedia ⬇️

A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola ⬇️

Acute parvovirus B19 infection mimicking congenital dyserythropoietic anemia

An accurate and inexpensive color-based assay for detecting severe anemia in a limited-resource setting

AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settings

Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia

Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions ⬇️

Brown recluse spider (Loxosceles reclusa) envenomation leading to acute hemolytic anemia in six adolescents

Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial

Case Report: β-thalassemia major on the East African coast

Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease

Chemical and functional analysis of generic hydroxyurea formulations

Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease

Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure

Chronic transfusion practice for children with sickle cell anaemia and stroke

Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities ⬇️

Clinical Features of β-Thalassemia and Sickle Cell Disease

Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children

Current Management of Sickle Cell Anemia ⬇️

Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia

Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults

EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.

Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study

Effect of hydroxyurea treatment on renal function parameters: Results from the multi‐center placebo‐controlled BABY HUG clinical trial for infants with sickle cell anemia ⬇️

Effective screening leads to better outcomes in sickle cell disease

Effects of hydroxyurea treatment for patients with hemoglobin SC disease

Electrochemical Determination of Hydroxyurea in a Complex Biological Matrix Using MoS<sub>2</sub>-Modified Electrodes and Chemometrics

Empowering newborn screening programs in African countries through establishment of an international collaborative effort

Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia

Evidence gaps in the management of sickle cell disease: A summary of needed research

From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia

Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia

Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia ⬇️

Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes ⬇️

Genetic predictors for stroke in children with sickle cell anemia ⬇️

Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY‐HUG phase III clinical trial ⬇️

Glomerular hyperfiltration and albuminuria in children with sickle cell anemia ⬇️

Hemodynamic responses to visual stimulation in children with sickle cell anemia

Hemoglobin variants identified in the Uganda Sickle Surveillance Study

Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority tria

Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa

Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS)

Hydroxyurea Pharmacokinetics in Pediatric Patients After Total Pancreatectomy With Islet Autotransplantation

Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

Hydroxyurea for children with sickle cell anemia: Prescribe it early and often

Hydroxyurea for children with sickle cell disease

Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? ⬇️

Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease

Hydroxyurea therapy for sickle cell anemia

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia

Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin

Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model

Hydroxyurea to lower TCD velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort

Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia ⬇️

Hydroxyurea: Analytical techniques and quantitative analysis

Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease.

IgA‐mediated autoimmune hemolytic anemia in an infant ⬇️

Immunologic effects of hydroxyurea in sickle cell anemia

Impact of hydroxyurea on clinical events in the BABY HUG trial

Interpretation of fetal hemoglobin only on newborn screening for hemoglobinopathy

Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohorts.

Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease

Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study

Long‐term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload ⬇️

Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial

Malignancy in patients with sickle cell disease

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members

Massive accidental overdose of hydroxyurea in a young child with sickle cell anemia ⬇️

Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia

The Clinical and Laboratory Spectrum of Hb C [β6(A3)Glu→Lys,GAG>AAG] Disease ⬇️